Torrent Expands Recall of Losartan-Containing Drugs, Citing NDEA Contamination




WASHINGTON, D.C. — India-based drug maker Torrent Pharmaceuticals Ltd. has expanded its voluntary recall of losartan-containing drugs due to N-nitrosodiethylamine (NDEA) contamination.

According to the Jan. 22 press release, NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC).

The impurity was reportedly found in an active pharmaceutical ingredient manufactured by Hetero Labs Ltd., also based in India. Torrent is only recalling lots of losartan-containing products that contain NDEA above the acceptable daily intake …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS



HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS